全球抗代谢药物市场 - 行业趋势及 2029 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球抗代谢药物市场 - 行业趋势及 2029 年预测

  • Oncology
  • Upcoming Report
  • Feb 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球抗代谢药物市场,类型(叶酸类似物、嘧啶类似物、嘌呤类似物)、应用(癌症治疗、抗生素、其他)、人口统计(成人、老年人、其他)、剂型(注射剂、乳膏剂、片剂、其他)、给药途径(口服、外用、静脉推注、静脉输注、持续输注)、最终用户(诊所、医院、其他)、分销渠道(医院药房、零售药房、网上药房)、国家(美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特,南非、中东和非洲其他地区)行业趋势及 2029 年预测

抗代谢药物市场

市场分析与洞察全球抗代谢药物市场

抗代谢药物市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称,在上述预测期内,市场复合年增长率将达到 7.60%。

抗代谢物是一种通过酶促反应抑制代谢物或破坏代谢途径的物质。嘌呤、嘧啶类似物和叶酸是抗代谢物。这些化合物是低分子量分子,是重要的化疗剂。这些物质的结构与核酸合成分子相似。它们用于治疗白血病、卵巢癌和胃肠道癌等疾病。这些药物对细胞周期有不利影响,因为它们会阻止细胞生长和分裂。因此,它们主要用作癌症化疗药物。抗代谢物用于多种用途,包括小梁切除术和抗生素。

The rise in the prevalence of cancer across the world will act a major driver for the expansion of anti-metabolite drugs market. Furthermore, upsurge in the number of pipe line studies and rising healthcare expenditure are the factors that will expand the anti-metabolite drugs market. Other factors including changing lifestyle and rising awareness will positively impact the market growth rate. Additionally, advancement in the medical technology, growing government funding and rising level of disposable incomes are the factors that will escalate the growth rate of anti-metabolite drugs market. Another significant factor influencing the growth rate of market is the increasing geriatric population. Also, growing number of cases of chronic disorders and rising concentration of global pharmaceutical companies will enhance the growth of market.

Moreover, the rise in the research and development activities, launch of new products and emerging new markets will provide beneficial opportunities for the anti-metabolite drugs market in the forecast period of 2022-2029. Also, high unmet need of current treatment and developments in healthcare technology will escalate the growth rate of market in future.

However, high cost associated with drugs and lack of infrastructure in low-income countries will impede the growth rate of market. Additionally, adverse effects linked with chemotherapies will hinder the market growth. Also, the dearth of awareness regarding health in many under-developed countries will further challenge the market in the forecast period mentioned above.

This anti-metabolite drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the anti-metabolite drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Anti-Metabolite Drugs Market Scope and Market Size

The anti-metabolite drugs market is segmented on the basis of type, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • 根据类型,抗代谢药物市场细分为叶酸类似物、嘧啶类似物和嘌呤类似物。嘌呤类似物细分为 6-巯基嘌呤、6-硫鸟嘌呤、硫唑嘌呤等。嘧啶类似物细分为 5-氟尿嘧啶、替加氟、卡培他滨等。叶酸类似物细分为甲氨蝶呤、培美曲塞、雷替曲塞等。
  • 根据应用,抗代谢药物市场分为癌症治疗药物、抗生素和其他药物。
  • 根据人口统计,抗代谢药物市场分为成人、老年人和其他。
  • 根据剂型,抗代谢药物市场分为注射剂、乳膏剂、片剂和其他剂型。
  • 根据给药途径,抗代谢药物市场分为口服、外用、静脉推注、静脉输注和持续输注。
  • 根据最终用户,抗代谢药物市场分为诊所、医院和其他。

抗代谢药物市场还根据分销渠道细分为医院药房、零售药房和网上药房。

抗代谢药物市场国家级分析

对抗代谢药物市场进行了分析,并按上述国家、类型、应用、人口统计、剂型、给药途径、最终用户和分销渠道提供了市场规模信息。

抗代谢药物市场报告涉及的国家 包括美国、加拿大、墨西哥、巴西、阿根廷、秘鲁、南美洲其他地区、德国、法国、英国、荷兰、瑞士、比利时、俄罗斯、意大利、西班牙、土耳其、匈牙利、立陶宛、奥地利、爱尔兰、挪威、波兰、欧洲其他地区、中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾、越南、亚太其他地区、沙特阿拉伯、阿联酋、埃及、以色列、科威特、南非、中东和非洲其他地区。

北美在抗代谢药物市场占据主导地位,因为该地区拥有主要关键参与者、高可支配收入和发达的医疗保健基础设施。由于该地区研发活动的增加、慢性病患病率的上升以及政府支持力度的加大,预计亚太地区将在 2022-2029 年预测期内实现增长。

报告的国家部分还提供了影响单个市场因素和国内市场法规变化,这些变化影响了市场的当前和未来趋势。新销售、替代销售、国家人口统计、疾病流行病学和进出口关税等数据点是用于预测单个国家市场情景的一些主要指标。此外,在对国家数据进行预测分析时,还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、销售渠道的影响。

患者流行病学分析

抗代谢药物市场还为您提供详细的市场分析,用于患者分析、预后和治疗。患病率、发病率、死亡率、依从率是报告中提供的一些数据变量。分析流行病学对市场增长的直接或间接影响,以创建更稳健、更队列的多元统计模型,用于预测增长期的市场。

竞争格局和全球抗代谢药物市场份额分析

抗代谢药物市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、公司优势和劣势、产品发布、临床试验渠道、产品批准、专利、产品宽度和广度、应用优势、技术生命线曲线。以上提供的数据点仅与公司对抗代谢药物市场研究的关注有关。

抗代谢药物市场的一些主要参与者包括 Teva Pharmaceutical Industries Ltd.、Fresenius Kabi India Pvt. Ltd.、CELON LABS、Cadila Pharmaceuticals、Eli Lilly and Company、Novartis AG、Amgen Inc.、AstraZeneca、Sanofi、Bristol-Myers Squibb Company、Merck & Co., Inc.、AbbVie Inc.、Janssen Pharmaceuticals, Inc.、Celldex Therapeutics、Biocon、F. Hoffmann-La Roche Ltd.、MacroGenics, Inc.、Johnson & Johnson Private Limited、Mylan NV、Abbott、Pfizer Inc.、GlaxoSmithKline plc 和 Sun Pharmaceutical Industries Ltd. 等。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.